VERTEX PHARMACEUTICALS INC / MA Operating Cash Flow
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Operating Cash Flow of $2.55 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $1.13B, a 4.87% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $1.43B, a 74.39% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $498.00M, a 14.81% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $1.24B, a 9.37% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for fiscal 2025 was $3.63B.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for fiscal 2024 was -$492.60M, a 113.93% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for fiscal 2023 was $3.54B, a 14.35% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) operating activities for fiscal 2022 was $4.13B, a 56.23% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.55B 10-Q · filed 2026-08-04 | $3.05B derived: sum of 3 quarters · filed 2026-08-04 | $4.29B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.43B 10-Q · filed 2026-05-05 | $1.93B derived: sum of 2 quarters · filed 2026-05-05 | $3.17B derived: sum of 3 quarters · filed 2026-05-05 | $4.24B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $498.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.74B derived: sum of 2 quarters · filed 2026-02-13 | $2.81B derived: sum of 3 quarters · filed 2026-08-04 | $3.63B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $1.24B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.31B derived: sum of 2 quarters · filed 2026-08-04 | $3.13B 10-Q · filed 2025-11-04 | $3.72B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $1.07B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.89B 10-Q · filed 2026-08-04 | $2.48B derived: sum of 3 quarters · filed 2026-08-04 | $3.85B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $818.90M 10-Q · filed 2026-05-05 | $1.40B derived: sum of 2 quarters · filed 2026-05-05 | $2.77B derived: sum of 3 quarters · filed 2026-05-05 | -$980.30M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $584.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.95B derived: sum of 2 quarters · filed 2026-02-13 | -$1.80B derived: sum of 3 quarters · filed 2026-02-13 | -$492.60M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $1.37B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.38B derived: sum of 2 quarters · filed 2025-11-04 | -$1.08B 10-Q · filed 2025-11-04 | -$842.60M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$3.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$2.45B 10-Q · filed 2025-08-05 | -$2.21B derived: sum of 3 quarters · filed 2026-02-13 | -$944.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $1.31B 10-Q · filed 2025-05-06 | $1.54B derived: sum of 2 quarters · filed 2026-02-13 | $2.81B derived: sum of 3 quarters · filed 2026-02-13 | $3.94B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $234.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.50B derived: sum of 2 quarters · filed 2026-02-13 | $2.64B derived: sum of 3 quarters · filed 2026-02-13 | $3.54B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $1.27B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.40B derived: sum of 2 quarters · filed 2024-11-05 | $3.30B 10-Q · filed 2024-11-05 | $4.38B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $1.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.03B 10-Q · filed 2024-08-02 | $3.11B derived: sum of 3 quarters · filed 2025-02-13 | $4.07B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $899.90M 10-Q · filed 2024-05-07 | $1.98B derived: sum of 2 quarters · filed 2025-02-13 | $2.93B derived: sum of 3 quarters · filed 2025-02-13 | $4.07B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $1.08B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.03B derived: sum of 2 quarters · filed 2025-02-13 | $3.17B derived: sum of 3 quarters · filed 2025-02-13 | $4.13B 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $955.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.10B derived: sum of 2 quarters · filed 2023-11-07 | $3.05B 10-Q · filed 2023-11-07 | $4.05B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $1.14B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.10B 10-Q · filed 2023-08-02 | $3.09B derived: sum of 3 quarters · filed 2024-02-15 | $4.02B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $956.20M 10-Q · filed 2023-05-02 | $1.95B derived: sum of 2 quarters · filed 2024-02-15 | $2.88B derived: sum of 3 quarters · filed 2024-02-15 | $2.68B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $995.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.92B derived: sum of 2 quarters · filed 2024-02-15 | $1.72B derived: sum of 3 quarters · filed 2024-02-15 | $2.64B 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $927.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $727.50M derived: sum of 2 quarters · filed 2022-10-28 | $1.65B 10-Q · filed 2022-10-28 | $1.65B 10-Q · filed 2021-11-03 | $2.14B derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | -$199.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $721.30M 10-Q · filed 2022-08-05 | $721.29M 10-Q · filed 2021-07-30 | $1.21B derived: sum of 3 quarters · filed 2023-02-10 | $2.12B derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | $921.00M 10-Q · filed 2022-05-06 | $921.05M 10-Q · filed 2021-04-30 | $1.41B derived: sum of 2 quarters · filed 2023-02-10 | $2.32B derived: sum of 3 quarters · filed 2023-02-10 | $3.36B derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $491.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.40B derived: sum of 2 quarters · filed 2023-02-10 | $2.44B derived: sum of 3 quarters · filed 2023-02-10 | $3.25B 10-K · filed 2023-02-10 | $3.25B 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $907.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.95B derived: sum of 2 quarters · filed 2021-11-03 | $2.76B 10-Q · filed 2021-11-03 | $3.21B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $1.04B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $1.85B 10-Q · filed 2021-07-30 | $2.30B derived: sum of 3 quarters · filed 2022-02-09 | $2.63B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $815.70M 10-Q · filed 2021-04-30 | $1.26B derived: sum of 2 quarters · filed 2022-02-09 | $1.60B derived: sum of 3 quarters · filed 2022-02-09 | $2.06B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $445.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $780.77M derived: sum of 2 quarters · filed 2022-02-09 | $1.24B derived: sum of 3 quarters · filed 2022-02-09 | $1.57B 10-K · filed 2022-02-09 | $1.57B 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $334.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $798.54M derived: sum of 2 quarters · filed 2020-10-30 | $1.12B 10-Q · filed 2020-10-30 | $1.44B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $463.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $788.53M 10-Q · filed 2020-07-31 | $1.10B derived: sum of 3 quarters · filed 2021-02-11 | $1.48B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $324.78M 10-Q · filed 2020-05-01 | $639.36M derived: sum of 2 quarters · filed 2021-02-11 | $1.02B derived: sum of 3 quarters · filed 2021-02-11 | $1.34B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $314.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $695.93M derived: sum of 2 quarters · filed 2021-02-11 | $1.02B derived: sum of 3 quarters · filed 2021-02-11 | $1.27B 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $381.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $703.05M derived: sum of 2 quarters · filed 2019-10-31 | $955.71M 10-Q · filed 2019-10-31 | $1.18B derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $321.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $574.36M 10-Q · filed 2019-08-01 | $801.87M derived: sum of 3 quarters · filed 2020-02-13 | $971.96M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $252.66M 10-Q · filed 2019-05-01 | $480.17M derived: sum of 2 quarters · filed 2020-02-13 | $650.25M derived: sum of 3 quarters · filed 2020-02-13 | $831.91M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $227.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $397.60M derived: sum of 2 quarters · filed 2020-02-13 | $579.25M derived: sum of 3 quarters · filed 2020-02-13 | $844.94M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $170.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $351.74M derived: sum of 2 quarters · filed 2018-10-25 | $617.43M 10-Q · filed 2018-10-25 | $762.15M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $181.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $447.35M 10-Q · filed 2018-07-26 | $592.07M derived: sum of 3 quarters · filed 2019-02-13 | $657.73M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $265.69M 10-Q · filed 2018-04-27 | $410.42M derived: sum of 2 quarters · filed 2019-02-13 | $476.07M derived: sum of 3 quarters · filed 2019-02-13 | $516.93M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $144.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $210.38M derived: sum of 2 quarters · filed 2019-02-13 | $251.24M derived: sum of 3 quarters · filed 2019-02-13 | $236.10M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $65.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $106.52M derived: sum of 2 quarters · filed 2017-10-30 | $91.38M 10-Q · filed 2017-10-30 | $120.52M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $40.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $25.72M 10-Q · filed 2017-07-28 | $54.87M derived: sum of 3 quarters · filed 2018-02-15 | -$7.21M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | -$15.14M 10-Q · filed 2017-04-28 | $14.01M derived: sum of 2 quarters · filed 2018-02-15 | -$48.07M derived: sum of 3 quarters · filed 2018-02-15 | -$158.33M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $29.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$32.93M derived: sum of 2 quarters · filed 2018-02-15 | -$143.20M derived: sum of 3 quarters · filed 2018-02-15 | -$365.43M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | -$62.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | -$172.34M derived: sum of 2 quarters · filed 2016-10-31 | -$394.57M 10-Q · filed 2016-10-31 | -$349.42M 10-Q · filed 2015-10-30 | -$576.36M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | -$110.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$332.50M 10-Q · filed 2016-08-01 | -$302.39M 10-Q · filed 2015-08-04 | -$514.28M derived: sum of 3 quarters · filed 2017-02-23 | -$601.93M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | -$222.24M 10-Q · filed 2016-05-03 | -$207.18M 10-Q · filed 2015-05-04 | -$404.02M derived: sum of 2 quarters · filed 2017-02-23 | -$491.67M derived: sum of 3 quarters · filed 2017-02-23 | -$619.59M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | -$181.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$269.43M derived: sum of 2 quarters · filed 2017-02-23 | -$397.35M derived: sum of 3 quarters · filed 2017-02-23 | -$573.11M 10-K · filed 2017-02-23 | -$513.20M 10-K · filed 2015-02-13 | |||
| 2014-09-30 | -$87.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$215.57M derived: sum of 2 quarters · filed 2015-10-30 | -$391.33M 10-Q · filed 2015-10-30 | -$371.57M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | -$127.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$303.68M 10-Q · filed 2015-08-04 | -$283.92M derived: sum of 3 quarters · filed 2016-02-16 | -$297.64M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | -$175.76M 10-Q · filed 2015-05-04 | -$156.00M derived: sum of 2 quarters · filed 2016-02-16 | -$169.72M derived: sum of 3 quarters · filed 2016-02-16 | -$170.65M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $19.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $6.04M derived: sum of 2 quarters · filed 2016-02-16 | $5.11M derived: sum of 3 quarters · filed 2016-02-16 | -$60.67M 10-K · filed 2016-02-16 | -$51.57M 10-K · filed 2014-02-11 | |||
| 2013-09-30 | -$13.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$14.65M derived: sum of 2 quarters · filed 2014-11-06 | -$80.42M 10-Q · filed 2014-11-06 | -$39.87M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$927.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$66.70M 10-Q · filed 2014-07-31 | -$26.15M derived: sum of 3 quarters · filed 2015-02-13 | $79.81M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | -$65.78M 10-Q · filed 2014-05-05 | -$25.22M derived: sum of 2 quarters · filed 2015-02-13 | $80.74M derived: sum of 3 quarters · filed 2015-02-13 | $199.15M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $40.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $146.52M derived: sum of 2 quarters · filed 2015-02-13 | $264.93M derived: sum of 3 quarters · filed 2015-02-13 | $267.84M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $105.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $224.37M derived: sum of 2 quarters · filed 2013-11-07 | $227.28M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $118.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $121.32M 10-Q · filed 2013-08-02 | ||||||
| 2012-03-31 | $2.92M 10-Q · filed 2013-05-08 | |||||||
| 2011-12-31 | $143.74M 10-K · filed 2014-02-11 | |||||||
| 2011-06-30 | -$216.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$402.82M 10-Q · filed 2011-08-09 | -$568.93M derived: sum of 3 quarters · filed 2013-03-01 | -$732.92M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$186.63M 10-Q · filed 2011-05-06 | -$352.73M derived: sum of 2 quarters · filed 2013-03-01 | -$516.72M derived: sum of 3 quarters · filed 2013-03-01 | -$625.61M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | -$166.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$330.09M derived: sum of 2 quarters · filed 2013-03-01 | -$438.98M derived: sum of 3 quarters · filed 2013-03-01 | -$635.44M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | -$163.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$272.88M derived: sum of 2 quarters · filed 2011-08-09 | -$469.34M 10-Q · filed 2010-10-28 | -$571.67M derived: sum of 4 quarters · filed 2011-08-09 | ||||
| 2010-06-30 | -$108.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$305.35M 10-Q · filed 2011-08-09 | -$407.68M derived: sum of 3 quarters · filed 2011-08-09 | -$429.31M derived: sum of 4 quarters · filed 2011-08-09 | ||||
| 2010-03-31 | -$196.46M 10-Q · filed 2011-05-06 | -$298.79M derived: sum of 2 quarters · filed 2011-05-06 | -$320.42M derived: sum of 3 quarters · filed 2011-05-06 | -$438.49M derived: sum of 4 quarters · filed 2011-05-06 | ||||
| 2009-12-31 | -$102.33M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | -$123.96M derived: sum of 2 quarters · filed 2011-02-17 | -$242.03M derived: sum of 3 quarters · filed 2011-02-17 | -$427.59M 10-K · filed 2011-02-17 | ||||
| 2009-09-30 | -$21.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$139.70M derived: sum of 2 quarters · filed 2010-10-28 | -$325.26M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | -$118.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | -$303.62M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | -$185.56M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | -$226.48M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |